FSTL1 and prostate cancer: Contrarily, increased expression of FSTL1 as opposed to healthy tissue was observed in brain cancer, castration-resistant prostate cancer, in most cases of hepatocellular carcinoma (HCC), squamous cell carcinoma of the head, neck, and esophagus [32,79,83].